Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Hyatt Hotels Corporation (H) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Hyatt Hotels Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Hyatt Hotels Corporation trades at $160.32 (market cap $15.11B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2× Hyatt Hotels Corporation's market cap, and Hyatt Hotels Corporation pays the higher dividend (0.37%). Which is the better fit depends on your goals.
| GEHC | H | |
|---|---|---|
Market Cap | $30.93B | $15.11B |
Volume | 5,033,451 | 769,803 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $202.09 |
52-Week Low | $59.48 | $135.42 |
Enterprise Value | $39.39B | $19.01B |
Dividend Yield | 0.23% | 0.37% |
Typical Hold Time | — | 149 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Hyatt Hotels (H) trades at $162.92, up 1.08% on the day, with a bullish technical signal and recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. The stock is supported by a consensus price target of $197.92, representing a 21% upside, and positive news including a strategic loyalty collaboration with Delta Air Lines and portfolio expansion. However, valuation metrics like a P/E of 197.93 and a net income margin of 1.1% indicate premium pricing relative to modest profitability.
The outlook for H is cautiously optimistic, driven by earnings momentum and strategic initiatives, but high valuation and fluctuating cash flows pose risks. Investors should weigh the potential for continued operational growth against the stock's rich multiples and macroeconomic sensitivity in the hospitality sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Hyatt Hotels Corporation
Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →
